Skip to main content

Alternatives to Ozempic

7 alternatives found

O

Ozempic (semaglutide) is a once-weekly injectable medication developed by Novo Nordisk, FDA-approved in 2017 for the treatment of type 2 diabetes. Its active ingredient, semaglutide, is a GLP-1 receptor agonist that works by stimulating insulin secretion, reducing glucagon production, and significantly decreasing appetite by slowing gastric emptying and acting on brain satiety centers.

About Ozempic

Get the best comparisons in your inbox

Weekly digest of trending comparisons, new categories, and expert insights. No spam.

Join 1,000+ readers. Unsubscribe anytime.